Vaccine Excipient Suppliers in India: What

Manufacturers Need to Know in 2025

India manufactures more than 60 percent of the world's vaccines. From BCG and polio

vaccines to COVID-19 vaccines and now mRNA products in development, Indian vaccine

manufacturers supply to national immunization programs across more than 150 countries.

Behind every successful vaccine is a carefully designed formulation. And that formulation

depends on a range of excipients that most people outside the industry never think about.

Excipients stabilize the vaccine antigen, preserve potency through the cold chain, help the

immune system respond appropriately, and keep the product safe for injection.

Finding reliable vaccine excipient suppliers in India with the right quality documentation and

regulatory compliance is a real challenge. This guide breaks down everything formulators,

procurement teams, and R&D scientists need to know.

What Are Vaccine Excipients?

Vaccine excipients are all the non-antigenic components in a vaccine formulation. They

include stabilizers, adjuvants, buffers, tonicity agents, preservatives, surfactants, and residual

manufacturing materials.

Unlike excipients in conventional injectables, vaccine excipients have some unique

characteristics:

? They must be compatible with biological antigens (proteins, polysaccharides, viral

particles, mRNA)

? They must maintain vaccine potency through thermal stress, freeze-thaw cycles, and

long-term storage

? Some, like adjuvants, directly influence the immune response

? They must have extremely low endotoxin levels to avoid triggering non-specific

immune reactions

? All components must be declared in the product's regulatory submission (IND, NDA,

BLA, WHO PQ dossier)

Types of Vaccine Excipients and Their Functions

Stabilizers

Stabilizers protect the vaccine antigen from degradation. In lyophilized (freeze-dried)

vaccines, stabilizers preserve the biological activity of the antigen during the drying and

reconstitution process.

Common stabilizers used in vaccines include:

? Sucrose and trehalose (disaccharide cryoprotectants widely used in lyophilized

biologics)

? Human serum albumin (HSA) used at low concentrations in some live virus vaccines

? Gelatin (used historically in MMR and varicella vaccines, though being phased out in

some products)

? Pharmaceutical-grade collagen peptides and low-endotoxin gelatin alternatives

Adjuvants

Adjuvants enhance the immune response to the vaccine antigen, allowing lower antigen doses

to be used and improving protection. Common adjuvants include:

? Aluminum hydroxide (Alhydrogel) and aluminum phosphate for traditional vaccines

? AS04, MF59, and AS01B for more advanced vaccine platforms

? CpG oligonucleotides for hepatitis B and certain next-generation vaccines

Adjuvant excipient quality is particularly critical because adjuvants are designed to activate

the immune system, and any quality deviation can affect both safety and efficacy.

Buffers

Maintaining a stable pH is essential for vaccine integrity. Common buffers in vaccine

formulations include:

? Phosphate buffered saline (PBS) for many conventional vaccines

? Histidine buffer for protein subunit vaccines and mRNA lipid nanoparticle

formulations

? Tris buffer for certain gene therapy and vaccine applications

Tonicity Agents

Sodium chloride is the most common tonicity agent used in vaccine formulations to achieve

isotonic conditions. In some products, mannitol or sorbitol may be used in combination.

Surfactants

Polysorbate 20 and polysorbate 80 are widely used in vaccine formulations to stabilize

protein antigens and prevent aggregation. In mRNA vaccine formulations using lipid

nanoparticles (LNPs), PEGylated lipids and other surfactant components are critical to the

delivery system.

Preservatives

Multi-dose vaccine vials require preservatives to prevent microbial contamination.

Thiomersal (thimerosal) is still used in some WHO-recommended multi-dose vaccine

formats, particularly in developing country programs. Phenol and 2-phenoxyethanol are used

in others.

pH Modifiers

Sodium hydroxide and hydrochloric acid are used to adjust and fine-tune pH during vaccine

manufacturing. While not functional excipients in the traditional sense, their pharmaceutical

grade is important.

The Regulatory Landscape for Vaccine Excipients in India

Vaccine manufacturing in India is regulated by CDSCO (Central Drugs Standard Control

Organisation) under the Ministry of Health. For vaccine products intended for international

markets or WHO prequalification, additional requirements apply.

Domestic Requirements

The Drugs and Cosmetics Act and its associated schedules govern all pharmaceutical and

vaccine manufacturing in India. Schedule M lays out GMP requirements for biological

products including vaccines.

WHO Prequalification

Many Indian vaccine manufacturers export to UNICEF and UN agencies under WHO

prequalification. All excipients used in a WHO PQ product must be listed in the dossier with

specifications, CoAs, and supplier information.

USFDA Biologics License Application (BLA)

For US market access, each excipient in a vaccine must be documented with pharmacopoeial

references or a master file. USFDA inspects vaccine manufacturing facilities and can raise

queries about excipient sourcing and qualification.

EMA (European Medicines Agency)

European market requirements demand that excipients meet EP specifications and that

manufacturers maintain a complete supply chain traceability system.

Key Challenges for Indian Vaccine Manufacturers in

Sourcing Excipients

Import Dependency

Despite India's vaccine manufacturing scale, many specialty vaccine excipients including

pharmaceutical-grade gelatin alternatives, low-endotoxin sucrose for lyophilization, and

adjuvant components are still primarily imported. European and Japanese manufacturers

dominate supply of these specialty ingredients.

mRNA Vaccine Excipients

The emergence of mRNA vaccines has introduced new excipient categories that are not yet

widely manufactured in India, including ionizable lipids, PEG-lipids, and DSPC

(distearoylphosphatidylcholine). Supply of these components for India's mRNA vaccine

development programs depends almost entirely on international suppliers.

Documentation Complexity

Vaccine regulatory submissions require comprehensive excipient documentation including

certificates of origin, GMP certificates, detailed specifications, and pharmacopoeial

compliance certificates. Many smaller Indian excipient suppliers are not equipped to provide

the full documentation package required for WHO PQ or USFDA filings.

Cold Chain Compatibility Testing

Excipients in vaccines must be validated not just for chemical compatibility with the antigen

but also for performance under the specific cold chain conditions of the target markets. This

requires specialized stability testing capabilities.

What to Look for in a Vaccine Excipient Supplier in India

When qualifying a vaccine excipient supplier, your checklist should include:

1. Pharmacopoeial monograph compliance (USP, EP, JP as applicable)

2. Batch-specific endotoxin testing reports

3. GMP certification of the manufacturing site

4. Ability to supply a completed Excipient Information Package (EIP)

5. Regulatory support including DMF availability or ability to support dossier

requirements

6. Stability data under relevant storage conditions

7. Track record of supply to vaccine manufacturers

Clyzo (clyzo.com) specifically maintains a category for vaccine-grade excipients with low

endotoxin pharma-grade products designed for vaccine formulation and production. The

platform also provides access to regulatory documentation directly, which is a major

advantage for manufacturers working under tight dossier timelines.

Emerging Trends in Vaccine Excipient Use in India

Shift to Preservative-Free Multi-Dose Formats

There is a global push to eliminate thiomersal from vaccines. This is driving development of

new preservative systems and container closure innovations that reduce the need for

traditional preservatives.

Next-Generation Adjuvants

India's vaccine R&D pipeline includes candidates using novel adjuvant systems. Sourcing

high-purity adjuvant components domestically is still limited but growing.

Collagen Peptides and Gelatin Alternatives

Traditional gelatin-based stabilizers are under scrutiny due to religious, ethical, and

allergenicity concerns. Plant-derived and recombinant alternatives are being explored.

Products like VACCIPRO (a collagen peptide for vaccine use) are examples of innovation in

this space.

Lipid Nanoparticle Excipients

As Indian companies progress in mRNA vaccine development, demand for pharmaceutical-

grade ionizable lipids, helper lipids, PEG-lipids, and cholesterol meeting injectable

specifications will increase. This is currently one of the largest supply chain gaps in India's

vaccine ecosystem.

Frequently Asked Questions

What excipients are used in COVID-19 vaccines manufactured in India? The COVID-19

vaccines developed and manufactured in India, such as Covaxin (inactivated virus), use

excipients including aluminum hydroxide gel as adjuvant, phosphate buffers, sodium

chloride, and beta-propiolactone in the inactivation process. mRNA vaccines use lipid

nanoparticle components, PEG-lipids, and histidine buffers.

Is low-endotoxin sucrose available in India for vaccine lyophilization? Yes.

Pharmaceutical-grade, low-endotoxin sucrose meeting USP and EP specifications is available

through specialty excipient platforms like Clyzo (clyzo.com).

What is the role of polysorbate 80 in vaccine formulations? Polysorbate 80 is a surfactant

that prevents protein antigen aggregation, stabilizes emulsions, and in lipid nanoparticle-

based vaccines, supports the structural integrity of the delivery system.

How can Indian vaccine manufacturers improve excipient documentation for WHO PQ

submissions? Working with suppliers that provide full Excipient Information Packages

(EIPs), batch-specific CoAs with endotoxin data, and GMP certificates significantly

simplifies the dossier process. Platforms like Clyzo (clyzo.com) are built specifically to

provide this documentation alongside the product.

Published on clyzo.com | Vaccine excipient solutions for India's pharmaceutical and biotech

industry